Jefferies Upgrades Exelon(EXC.US) to Buy Rating, Raises Target Price to $46
Argus Research Initiates Exelon(EXC.US) With Buy Rating
Argus Research Keeps Their Buy Rating on Exelon (EXC)
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $42
Exelon (EXC) Receives a Hold From Morgan Stanley
Morgan Stanley Adjusts Price Target on Exelon to $42 From $39, Maintains Equalweight Rating
Exelon Analyst Ratings
RBC Capital Adjusts Price Target on Exelon to $40 From $41, Maintains Sector Perform Rating
Exelon Analyst Ratings
Wells Fargo Adjusts Price Target on Exelon to $42 From $40
Wells Fargo Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $42
Analysts' Top Utilities Picks: IdaCorp (IDA), Exelon (EXC)
KeyBanc Maintains Exelon(EXC.US) With Hold Rating
BofA Securities Initiates Exelon(EXC.US) With Hold Rating, Announces Target Price $39
Exelon's Strong Q2'24 Performance Overshadowed by Regulatory Uncertainties: Analyst Paul Cole's Neutral Stance
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Maintains Target Price $39
Exelon Price Target Raised to $41.00/Share From $39.00 by Barclays
Exelon Analyst Ratings
Barclays Maintains Exelon(EXC.US) With Buy Rating, Raises Target Price to $41